Correlates of postmenopausal female hormone use among black women in the United States

Obstetrics and Gynecology

Volumn 91, Issue 3, 1998, Pages 454-458

  Rosenberg, Lynn ^a   Palmer, Julie R ^a   Sowmya Rao, R ^a   Adams Campbell, Lucile L ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; EDUCATION; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; NEGRO; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; UNITED STATES; WOMEN'S HEALTH;

EID: 0032030629     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00699-6     Document Type: Article

References (24)

1. Scalley EK, Henrich JB. An overview of estrogen replacement therapy in postmenopausal women. J VVomens Health 1993;2:2S994.
2. Kennedy DL, Baum C, Forbes MB. Noncontraceptive estrogens and progestins: Use patterns over time. Obstet Gynecol 1985;65: 441-6.
3. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol 1995;85:6-10.
4. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: Estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45.
5. Stampfer MJ, Colditz GA, Wille WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-62.
6. Rosenberg L, Palmer JR, Shapiro S. A case-control study of myocardial infarction in relation to use of estrogen supplements. Am J Epidemiol 1993;137:54-63.
7. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438-44.
8. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;! 17:1016-36.
9. Rosenberg L. Hormone replacement therapy: The need for reconsideration. Am J Public Health 1993;83:1670-3. 10. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115:455-6.
10. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861-7.
11. Posthuma WFM, Westendorp RGJ, Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: Is the evidence biased? BMJ 1994;30S:1268-9.
12. Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women's Health Study: A follow-up study for causes and prevention of illness. J Am Mod Worn Assoc 1995;50:56-8.
13. Schlesselman JJ. Case-control studies: Design, conduct, analysis. New York: Oxford University Press, 1982:217-67.
14. Derby ÇA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 1993;137:1125-35.
15. Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439-52.
16. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769-75.
17. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Am Intern Med 1992;117:1038-41.
18. American College of Obstetrics and Gynecology. Hormone replacement therapy. ACOG technical bulletin no. 166. Washington, DC: American College of Obstetricians and Gynecologists, 1992.
19. The Writing Group for the PEPI Trial. Effects of estrogen or eslrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Intervention (PEPI) Trial. JAMA 1995;273:199-208.
20. Moorhead T, Hanneford P, Warskyj M. Prevalence and characteristics associated with the use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 1997;104:290-7.
21. Goodman MT, Nomura AMY, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990;131:81525.
22. Persson I, Bergkvist L, Adami H-O. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol 1987;16:222-8.
23. Spengler RF, Clarke EA, Woolever CA, Newman AM, Osborn RW. Exogenous estrogens and endometrial cancer: A case-control study and assessment of potential biases. Am J Epidemiol 1981;114:497506.
24. Kominski R, Adams A. Educational attainment in the United States: March 1991 and 1990. Current population characteristics. Series P-20, no. 462. US Dept. Commerce, May 1992.